Jupiter Neurosciences, Inc. (JUNS)

Jupiter Neurosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	-	-	0.23	0.64	1.13
Revenue Growth (YoY)	-	-	-63.44%	-43.35%	-
Cost of Revenue	0.49	0.95	0.94	1.45	1.64
Gross Profit	-0.49	-0.95	-0.71	-0.81	-0.52
Selling, General & Admin	2.6	2.92	2.72	3.1	1.34
Operating Expenses	2.6	2.92	2.72	3.1	1.34
Operating Income	-3.09	-3.87	-3.43	-3.91	-1.85
Interest Expense	-0.25	-0.22	-0.74	-0.11	-0.01
Interest & Investment Income	0.01	0	0	0	0
Other Non Operating Income (Expenses)	0.04	0.19	0.26	-0.09	0.28
EBT Excluding Unusual Items	-3.3	-3.9	-3.91	-4.11	-1.58
Other Unusual Items	0.86	-0.89	-1.05	-0.09	-0.07
Pretax Income	-2.44	-4.78	-4.96	-4.2	-1.65
Net Income	-2.44	-4.78	-4.96	-4.2	-1.65
Net Income to Common	-2.44	-4.78	-4.96	-4.2	-1.65
Shares Outstanding (Basic)	29	26	25	24	22
Shares Outstanding (Diluted)	29	26	25	24	22
Shares Change (YoY)	9.01%	3.75%	6.69%	9.51%	5.01%
EPS (Basic)	-0.08	-0.18	-0.19	-0.18	-0.08
EPS (Diluted)	-0.08	-0.18	-0.19	-0.18	-0.08
Gross Margin	-	-	-	-126.90%	-45.74%
Operating Margin	-	-	-1471.38%	-612.36%	-164.41%
Profit Margin	-	-	-2125.15%	-658.31%	-146.92%
EBIT	-3.09	-3.87	-3.43	-3.91	-1.85
EBIT Margin	-	-	-	-	-164.41%

Updated Dec 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q